Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
Breast cancer is the most common malignancy and second leading cause of cancer death in women. Ninety percent of mortality in breast cancer is often associated with metastatic progression or relapse in patients. Critical stages in the development of aggressive breast cancer include the growth of pri...
Gespeichert in:
| Veröffentlicht in: | Clinical & experimental metastasis 2010-02, Vol.27 (2), p.97-105 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 105 |
|---|---|
| container_issue | 2 |
| container_start_page | 97 |
| container_title | Clinical & experimental metastasis |
| container_volume | 27 |
| creator | Hinton, Cimona V Avraham, Shalom Avraham, Hava Karsenty |
| description | Breast cancer is the most common malignancy and second leading cause of cancer death in women. Ninety percent of mortality in breast cancer is often associated with metastatic progression or relapse in patients. Critical stages in the development of aggressive breast cancer include the growth of primary tumors and their ability to spread to foreign organs and form metastases, as well as the establishment of an independent blood supply within the new tumors. Hence, it is imperative to characterize the key molecules that regulate the metastasis of human breast cancer cells. The expression of CXCR4/CXCL12 in breast tumors has been correlated with a poor prognosis, increased metastasis, resistance to conventional therapeutic agents and a poor outcome in the pathogenesis of breast cancer. However, effective anti-CXCR4 therapy remains a challenge. Here, we will review the putative involvement of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Characterization of signaling events important for breast cancer cell growth and their metastasis to the brain should provide insights into breast cancer therapies and improved, successful treatments for breast cancer. |
| doi_str_mv | 10.1007/s10585-008-9210-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733643460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733643460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-e0ab0be750eee66bb39e04d192102902c52238a148a71e5bb8b14879ca3081be3</originalsourceid><addsrcrecordid>eNp9kUtrGzEUhUVpaFw3P6CbVnTTbia5V4-RZllMXmBISBPITkiTa3fCeMaVxpD8-8gZg6ELb_TgfueIo8PYV4RTBDBnCUFbXQDYohIIhfjAJqiNLIww5Uc2AVGKAmxlj9nnlJ4BQBljP7FjtBYVKDFht3d9S7xf8OEv8dnj7E6d5XWOgqdm2fm26ZbcvzSJNx0PkXwaeO27miJf0ZBvPuXZ0L_LQ_RN94UdLXyb6GS3T9nDxfn97KqY31xez37Pi1pVcigIfIBARgMRlWUIsiJQT7jNISoQtRZCWo_KeoOkQ7Ahn01VewkWA8kp-zn6rmP_b0NpcKsm1dS2vqN-k5yRslRSlZDJXwdJNNoKWaEUGf3xH_rcb2L-huQEqgxqbTOEI1THPqVIC7eOzcrHV4fgtr24sReXe3HbPG5r_G1nvAkretordkVkQIxAyqNuSXH_8iHX76No4Xvnl7FJ7uGPAJSA2RZz9jcppJ2G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214175558</pqid></control><display><type>article</type><title>Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Hinton, Cimona V ; Avraham, Shalom ; Avraham, Hava Karsenty</creator><creatorcontrib>Hinton, Cimona V ; Avraham, Shalom ; Avraham, Hava Karsenty</creatorcontrib><description>Breast cancer is the most common malignancy and second leading cause of cancer death in women. Ninety percent of mortality in breast cancer is often associated with metastatic progression or relapse in patients. Critical stages in the development of aggressive breast cancer include the growth of primary tumors and their ability to spread to foreign organs and form metastases, as well as the establishment of an independent blood supply within the new tumors. Hence, it is imperative to characterize the key molecules that regulate the metastasis of human breast cancer cells. The expression of CXCR4/CXCL12 in breast tumors has been correlated with a poor prognosis, increased metastasis, resistance to conventional therapeutic agents and a poor outcome in the pathogenesis of breast cancer. However, effective anti-CXCR4 therapy remains a challenge. Here, we will review the putative involvement of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Characterization of signaling events important for breast cancer cell growth and their metastasis to the brain should provide insights into breast cancer therapies and improved, successful treatments for breast cancer.</description><identifier>ISSN: 0262-0898</identifier><identifier>EISSN: 1573-7276</identifier><identifier>DOI: 10.1007/s10585-008-9210-2</identifier><identifier>PMID: 18814042</identifier><identifier>CODEN: CEXMD2</identifier><language>eng</language><publisher>Dordrecht: Dordrecht : Springer Netherlands</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Brain Neoplasms - metabolism ; Brain Neoplasms - secondary ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Cancer Research ; Chemokine CXCL12 - metabolism ; Chemokine CXCL12 - physiology ; Female ; Hematology ; Humans ; Intercellular Signaling Peptides and Proteins - metabolism ; Oncology ; Receptors, CXCR4 - metabolism ; Receptors, CXCR4 - physiology ; Review ; Signal Transduction - physiology ; Surgical Oncology</subject><ispartof>Clinical & experimental metastasis, 2010-02, Vol.27 (2), p.97-105</ispartof><rights>Springer Science+Business Media B.V. 2008</rights><rights>Springer Science+Business Media B.V. 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-e0ab0be750eee66bb39e04d192102902c52238a148a71e5bb8b14879ca3081be3</citedby><cites>FETCH-LOGICAL-c493t-e0ab0be750eee66bb39e04d192102902c52238a148a71e5bb8b14879ca3081be3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10585-008-9210-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10585-008-9210-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18814042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hinton, Cimona V</creatorcontrib><creatorcontrib>Avraham, Shalom</creatorcontrib><creatorcontrib>Avraham, Hava Karsenty</creatorcontrib><title>Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain</title><title>Clinical & experimental metastasis</title><addtitle>Clin Exp Metastasis</addtitle><addtitle>Clin Exp Metastasis</addtitle><description>Breast cancer is the most common malignancy and second leading cause of cancer death in women. Ninety percent of mortality in breast cancer is often associated with metastatic progression or relapse in patients. Critical stages in the development of aggressive breast cancer include the growth of primary tumors and their ability to spread to foreign organs and form metastases, as well as the establishment of an independent blood supply within the new tumors. Hence, it is imperative to characterize the key molecules that regulate the metastasis of human breast cancer cells. The expression of CXCR4/CXCL12 in breast tumors has been correlated with a poor prognosis, increased metastasis, resistance to conventional therapeutic agents and a poor outcome in the pathogenesis of breast cancer. However, effective anti-CXCR4 therapy remains a challenge. Here, we will review the putative involvement of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Characterization of signaling events important for breast cancer cell growth and their metastasis to the brain should provide insights into breast cancer therapies and improved, successful treatments for breast cancer.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain Neoplasms - metabolism</subject><subject>Brain Neoplasms - secondary</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer Research</subject><subject>Chemokine CXCL12 - metabolism</subject><subject>Chemokine CXCL12 - physiology</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Intercellular Signaling Peptides and Proteins - metabolism</subject><subject>Oncology</subject><subject>Receptors, CXCR4 - metabolism</subject><subject>Receptors, CXCR4 - physiology</subject><subject>Review</subject><subject>Signal Transduction - physiology</subject><subject>Surgical Oncology</subject><issn>0262-0898</issn><issn>1573-7276</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kUtrGzEUhUVpaFw3P6CbVnTTbia5V4-RZllMXmBISBPITkiTa3fCeMaVxpD8-8gZg6ELb_TgfueIo8PYV4RTBDBnCUFbXQDYohIIhfjAJqiNLIww5Uc2AVGKAmxlj9nnlJ4BQBljP7FjtBYVKDFht3d9S7xf8OEv8dnj7E6d5XWOgqdm2fm26ZbcvzSJNx0PkXwaeO27miJf0ZBvPuXZ0L_LQ_RN94UdLXyb6GS3T9nDxfn97KqY31xez37Pi1pVcigIfIBARgMRlWUIsiJQT7jNISoQtRZCWo_KeoOkQ7Ahn01VewkWA8kp-zn6rmP_b0NpcKsm1dS2vqN-k5yRslRSlZDJXwdJNNoKWaEUGf3xH_rcb2L-huQEqgxqbTOEI1THPqVIC7eOzcrHV4fgtr24sReXe3HbPG5r_G1nvAkretordkVkQIxAyqNuSXH_8iHX76No4Xvnl7FJ7uGPAJSA2RZz9jcppJ2G</recordid><startdate>20100201</startdate><enddate>20100201</enddate><creator>Hinton, Cimona V</creator><creator>Avraham, Shalom</creator><creator>Avraham, Hava Karsenty</creator><general>Dordrecht : Springer Netherlands</general><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20100201</creationdate><title>Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain</title><author>Hinton, Cimona V ; Avraham, Shalom ; Avraham, Hava Karsenty</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-e0ab0be750eee66bb39e04d192102902c52238a148a71e5bb8b14879ca3081be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain Neoplasms - metabolism</topic><topic>Brain Neoplasms - secondary</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer Research</topic><topic>Chemokine CXCL12 - metabolism</topic><topic>Chemokine CXCL12 - physiology</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Intercellular Signaling Peptides and Proteins - metabolism</topic><topic>Oncology</topic><topic>Receptors, CXCR4 - metabolism</topic><topic>Receptors, CXCR4 - physiology</topic><topic>Review</topic><topic>Signal Transduction - physiology</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hinton, Cimona V</creatorcontrib><creatorcontrib>Avraham, Shalom</creatorcontrib><creatorcontrib>Avraham, Hava Karsenty</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical & experimental metastasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hinton, Cimona V</au><au>Avraham, Shalom</au><au>Avraham, Hava Karsenty</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain</atitle><jtitle>Clinical & experimental metastasis</jtitle><stitle>Clin Exp Metastasis</stitle><addtitle>Clin Exp Metastasis</addtitle><date>2010-02-01</date><risdate>2010</risdate><volume>27</volume><issue>2</issue><spage>97</spage><epage>105</epage><pages>97-105</pages><issn>0262-0898</issn><eissn>1573-7276</eissn><coden>CEXMD2</coden><abstract>Breast cancer is the most common malignancy and second leading cause of cancer death in women. Ninety percent of mortality in breast cancer is often associated with metastatic progression or relapse in patients. Critical stages in the development of aggressive breast cancer include the growth of primary tumors and their ability to spread to foreign organs and form metastases, as well as the establishment of an independent blood supply within the new tumors. Hence, it is imperative to characterize the key molecules that regulate the metastasis of human breast cancer cells. The expression of CXCR4/CXCL12 in breast tumors has been correlated with a poor prognosis, increased metastasis, resistance to conventional therapeutic agents and a poor outcome in the pathogenesis of breast cancer. However, effective anti-CXCR4 therapy remains a challenge. Here, we will review the putative involvement of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Characterization of signaling events important for breast cancer cell growth and their metastasis to the brain should provide insights into breast cancer therapies and improved, successful treatments for breast cancer.</abstract><cop>Dordrecht</cop><pub>Dordrecht : Springer Netherlands</pub><pmid>18814042</pmid><doi>10.1007/s10585-008-9210-2</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0262-0898 |
| ispartof | Clinical & experimental metastasis, 2010-02, Vol.27 (2), p.97-105 |
| issn | 0262-0898 1573-7276 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733643460 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Biomedical and Life Sciences Biomedicine Brain Neoplasms - metabolism Brain Neoplasms - secondary Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer Research Chemokine CXCL12 - metabolism Chemokine CXCL12 - physiology Female Hematology Humans Intercellular Signaling Peptides and Proteins - metabolism Oncology Receptors, CXCR4 - metabolism Receptors, CXCR4 - physiology Review Signal Transduction - physiology Surgical Oncology |
| title | Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A00%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20the%20CXCR4/CXCL12%20signaling%20axis%20in%20breast%20cancer%20metastasis%20to%20the%20brain&rft.jtitle=Clinical%20&%20experimental%20metastasis&rft.au=Hinton,%20Cimona%20V&rft.date=2010-02-01&rft.volume=27&rft.issue=2&rft.spage=97&rft.epage=105&rft.pages=97-105&rft.issn=0262-0898&rft.eissn=1573-7276&rft.coden=CEXMD2&rft_id=info:doi/10.1007/s10585-008-9210-2&rft_dat=%3Cproquest_cross%3E733643460%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214175558&rft_id=info:pmid/18814042&rfr_iscdi=true |